Dr. Reddy's launches generic Invanz
The Invanz brand and generic had a market value of $205 million for the 12 months ended March 2021, according to IQVIA.
Dr. Reddy’s is introducing ertapenem for injection, 1 g/vial.
The product is the generic of Merck's Invanz.
The Invanz brand and generic had a market value of $205 million for the 12 months ended March 2021, according to IQVIA.
Dr. Reddy’s product is available in packs of 10 vials per carton.